Dr Donald Grant, GP and Senior Clinical Advisor at The Independent Pharmacy, warned it is 'crucial' to transition under ...

The company said it was reviewing Mounjaro pricing with other governments and expected to make similar adjustments in certain markets from September 1 ...

A woman who lost six-and-a-half stone on weight-loss jab Mounjaro has marked her transformation with a tattoo. Siân Robinson, 32, from Worcester, once weighed nearly 29st and feared she wouldn’t make ...

Watch the full special here: <a href="https://youtu.be/r99fnQP8wrc">https://youtu.be/r99fnQP8wrc</a> Catch @toddbarry at ...

Blockbuster weight loss jabs relied on by millions not be the quick fix many believe it to be, experts warn, as users pil on ...

Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...

Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy according to analysts. On August 14, Eli Lilly and ...

Eli Lilly and Company (NYSE:LLY)’s pipeline has been advancing, thanks to positive study results in oncology and ...

Eli Lilly & Co. raises Mounjaro prices in the United Kingdom to reduce costs in the U.S. Weight-loss drug prices increase by 170% in the U.K., but its National Health Service prices remained unchanged ...

The integration aims to simplify access to Zepbound for eligible members while providing comprehensive, whole-person care to ...

Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight, potentially transforming diabetes and obesity treatment.